CIRM Discusses $70M Plan To Develop ‘Alpha Clinics’
During a recent interview with the Los Angeles Times, California Institute for Regenerative Medicine President Alan Trounson announced that CIRM is developing a $70-million plan to establish "alpha clinics" statewide as part of a strategy to cut costs and accelerate enrollment in clinical trials for stem cell therapies. CIRM's governing board is expected to vote on the plan later this year.
- "CIRM's $70 Million Push To Speed Stem Cell Therapies" (Leuty, "SFBiotech," San Francisco Business Times, 5/29).